group presentation- amgen unveils its kras inhibitor
Published 2 years ago • 39 plays • Length 6:23Download video MP4
Download video MP3
Similar videos
-
9:36
2022 aanem - ucb presented new additional data from its generalized myasthenia gravis portfolio
-
1:41
amgen at esc 2023
-
0:26
our understanding of igg4-rd is ever-evolving. visit amgen.com to learn more. #rarediseases
-
19:27
stage ii cutaneous melanoma explained
-
5:19
battling melanoma: brooke wilson shares her story
-
51:17
neuromuscular academy webinar: monitoring myasthenia gravis in clinic - choosing outcome measures
-
16:14
why multicolor imaging... – min wang md phd
-
1:35
actrims research priorities
-
1:28
highlights from esmo 2022 in melanoma
-
2:18
aslms / vascular birthmarks foundation joint project
-
19:46
overview
-
2:41
immunotherapies for satellite or itm melanoma
-
14:02
options for stage ii and stage iii melanoma: factors when considering a plan that is right for you
-
5:45
considerations for ngs testing in mtnbc
-
1:29
advances and unmet needs for breast cancer
-
23:15
immunotherapy in melanoma
-
3:30
ams - die & mould video
-
3:33
every patient counts, every story matters: robin and michael discuss multiple myeloma
-
3:51
molecular testing for stage iii melanoma
-
11:56
welcome - overview of melanoma
-
1:42
#amjmed launches 'gold open access' journal